No, progesterone should not be administered every other day as an alternative to higher daily doses during manufacturer backorders.
Progesterone for endometrial protection requires consistent daily dosing at established therapeutic levels, and every-other-day administration does not provide adequate endometrial protection or maintain appropriate therapeutic serum levels. The evidence clearly demonstrates that dosing frequency is critical for efficacy.
Why Every-Other-Day Dosing is Inadequate
The available guideline evidence specifically addresses dosing schedules for progesterone in hormone replacement therapy. Sequential regimens require 200 mg of oral (or vaginal) micronized progesterone daily for 12-14 days every 28 days 1. This daily dosing during the progestogen phase is essential for endometrial protection.
While one research study examined vaginal progesterone administered every other day at 45 mg, 90 mg, or 180 mg doses 2, this was in a highly controlled research setting with ovarian suppression and concurrent estradiol therapy. Importantly, this study showed that even with every-other-day dosing, plasma progesterone levels were significantly lower in the 45 mg group (2.4 ng/mL) compared to higher doses (3.6-3.4 ng/mL), though endometrial transformation was observed due to the "first uterine pass effect" with vaginal administration.
Evidence-Based Alternatives During Shortages
Instead of every-other-day dosing, consider these evidence-based alternatives:
For Sequential Regimens (12-14 days per month):
- Oral micronized progesterone: 200 mg daily provides endometrial protection for up to 5 years 3
- Vaginal micronized progesterone: 100 mg daily (though off-label) or 4% gel (45 mg/day) for 10+ days per month may provide protection for 3-5 years 3
- Alternative progestogens: Medroxyprogesterone acetate 10 mg daily or dydrogesterone 10 mg daily for 12-14 days per month 1
For Continuous Regimens:
- Minimum doses: norethisterone 1 mg daily, medroxyprogesterone acetate 2.5 mg daily, or dydrogesterone 5 mg daily 1
Critical Pitfalls to Avoid
Do not attempt to compensate for supply shortages by:
- Doubling doses on alternate days (not evidence-based)
- Extending intervals between doses beyond 24 hours for daily regimens
- Assuming that higher doses every other day equal daily lower doses
The FDA-approved intramuscular progesterone dosing is 5-10 mg daily for 6-8 consecutive days 4, reinforcing that daily administration is the standard.
Practical Solution
If your usual progesterone formulation is unavailable, switch to an alternative progestogen at appropriate daily doses rather than altering the dosing frequency. Micronized progesterone remains the first choice due to lower cardiovascular and thromboembolism risk 1, but medroxyprogesterone acetate or dydrogesterone are acceptable alternatives when administered daily at appropriate doses.
The one exception where less frequent dosing has some evidence is in postmenopausal hormone therapy, where one study showed that combined estrogen-progestogen therapy every other day reduced triglyceride increases compared to daily therapy in overweight women 5. However, this was for combined therapy, not progesterone alone, and does not address endometrial protection adequacy.
Bottom line: Maintain daily dosing with an alternative progestogen formulation rather than compromising dosing frequency, as endometrial protection and therapeutic efficacy depend on consistent daily administration.